Israel: A Dispute Resolution: Class Action (Defence) Overview

Overview of Israeli Class Actions in 2026: From Surge to Strategy – Successfully Managing the Risk

Foreign counsels are often surprised by how quickly a class action in Israel can become a genuinely burdensome issue – even when the underlying allegation looks modest by global standards. The number of class actions filed in Israel rose exponentially over the past two decades, with more than 2,200 now being filed per year. Israel has developed an experienced class action judiciary and a class action litigation Bar shaped by strong consumer protection sentiment.

For multinational legal teams managing parallel exposures across jurisdictions, the practical takeaway is clear: success in Israel usually depends less on finding a procedural argument and more on building an early, evidence-based narrative that aligns with the company’s global strategy and priorities. Designed and executed properly, this can contain and dismiss the Israeli proceeding.

The Israeli class action landscape: global concept, local practice

Israel’s class action regime is built around the Class Actions Law, 2006, which created a uniform framework for representative proceedings across multiple fields. The growth has been dramatic.

The Class Actions Law allows class actions across a wide range of commercial and regulated contexts, including consumer protection, banking and insurance, securities, technology, competition, environmental, labour, accessibility and discrimination in services. It also permits class actions against administrative authorities seeking restitution of unlawfully collected payments (taxes, fees).

Notably, the majority of Israeli class actions have been consumer‑related, reflecting the law’s primary policy goal of promoting private enforcement of consumer rights.

Israeli class actions are adjudicated in two stages:

• certification (court approval to proceed as a class action); and
• litigation on the merits.

Every case starts with a motion to certify, typically supported by affidavits, documents and – frequently in complex matters – expert opinions. The average time to adjudicate each stage is around five years.

What matters most for foreign defendants is that certification in Israel is not merely a procedural gate. The court examines whether the claim has a “reasonable chance of success” in a way that requires real engagement with the merits and defences early on, alongside class requirements such as commonality, efficiency and adequacy. In-house teams should expect early pressure to produce a factual and expert-backed position, often while related events (a recall, regulator inquiry or parallel litigation abroad) are still unfolding.

At the same time, discovery during certification is generally limited, designed to prevent “fishing expeditions”. Wide-ranging e-discovery remains relatively uncommon (though it is rising in complex cross-border disputes). Depositions are not available.

The recent tendency in Israeli class action adjudication is pro-plaintiff, contributing to a relatively low certification bar. This judicial environment, combined with the economics of class actions and the fact that the costs ordered by courts in case of dismissal are on the low side, incentivizes frequent filings of new class actions. One of the immediate impacts of this situation is that even frivolous cases may not go away quickly.

Settlement and resolution

Israeli courts actively case-manage class actions, including encouraging settlements and mediated resolutions. A significant majority of cases result in settlements and withdrawals. Settlement approval is subject to the court's scrutiny, including publication, enabling objections by regulators and the public and requiring the Attorney General to file its position – and even allowing the court to appoint independent reviewers to test fairness. Israeli settlements are typically more modest than in the USA.

While in the past most certified class actions resulted in a settlement, the current trend suggests defendants are increasingly willing to litigate even after certification, partly because certification has become more common and therefore less determinative.

Copycat filings: when overseas litigation and regulatory events spill over to Israel

A key characteristic of the Israeli class action practice is the speed with which overseas events can become local class actions. Israeli plaintiffs’ firms regularly monitor foreign class actions, judgments, recalls, press coverage, scientific publications and regulator decisions and attempt to “reformulate” them into Israeli claims. This is particularly relevant for multinationals in consumer products, food and beverage, pharmaceuticals and medical devices, automotive, fintech and technology-driven consumer services.

There are two strategic points that are valuable in managing Israeli copycat cases. First, it should be assumed that any global inconsistency will be exploited. Second, a major global settlement does not bind, but it may shape the optics.

“Breach of autonomy”: a uniquely Israeli risk

Israel’s “breach of autonomy” doctrine is a distinctive head of damage that can be asserted even where traditional physical or monetary harm is absent. It first evolved in medical informed consent contexts and later expanded into consumer-related matters, allowing claims based on alleged deprivation of an informed choice.

In class actions, this doctrine is attractive because it reduces and de facto eliminates the need to prove individualised damage and causation. For multinationals, this risk appears most often in scenarios involving labelling and marketing, product attributes (including trace ingredients/contaminants), digital disclosures and safety communications – and it can arise even where the underlying risk never materialised.

At the same time, the Israeli Supreme Court signals an effort to “tame” over-expansive autonomy claims through limitations such as requiring meaningful subjective harm and focusing on core autonomy interests. The practical defence takeaway is that breach-of-autonomy cases often turn on the details of the factual framing: what was disclosed, when, through which channel and to whom, and how a reasonable consumer or patient would have understood it in the right context. There are effective defence strategies to mitigate or entirely rebut the associated risk, before or after a class action is filed.

Heavily regulated industries: where compliance is necessary but not always sufficient

Class actions in Israel frequently arise in heavily regulated sectors where defendants assume that compliance should be a complete shield. In practice, courts may still scrutinise whether business conduct was fair and transparent to consumers, even where regulatory requirements were met, especially in sectors like pharmaceuticals and medical devices, automotive (safety and recalls), financial services (fees and disclosures), food labelling and consumer tech platforms.

Notably, two patterns recur:

• first, regulatory events (recalls, safety notices, regulatory inquiries, etc) become class action triggers; and
• second, the regulator's stance matters, and it is strategically valuable to show reliance of the regulator’s position in advance or after the case is submitted.

“Out-of-the-box” management: defend today’s exposure, avoid tomorrow’s filings

Israel’s high filing volume means that companies often need to think beyond the individual case. The goal is not only to defend or resolve the pending motion to certify, but also to do so in a way that does not create incentive for the next claim. Practical measures that often help include identifying the overarching strategy early on, building the record in advance, defending vigorously to boost the defendant's reputation, strategically timing settlements and ensuring full global alignment.

Summary: strategise, control, defend

Israel is a high-activity class action jurisdiction with a front-loaded certification process that requires early merits engagement, often supported by affidavits and experts. The pro-consumer orientation and importance of meaningful settlement mean that even modest disputes can feel operationally disruptive, particularly for foreign defendants managing cross-border issues and parallel exposures. For global in-house teams, the most reliable path to a cost-effective outcome is early strategic discipline: align the Israeli defence with the company’s global narrative, address regulated-industry context and anticipate Israel-specific doctrines such as breach of autonomy.